Literature DB >> 8369810

Allergic disorders in systemic lupus erythematosus.

J F Sequeira1, D Cesic, G Keser, M Bukelica, S Karanagnostis, M A Khamashta, G R Hughes.   

Abstract

Allergic disorders commonly occur in patients with systemic lupus erythematosus (SLE) and allergies to some drugs may occasionally be related to disease flares. We evaluated the prevalence of several types of allergy in 132 patients with SLE and their families and compared the SLE patients with a control group of 66 patients with non-lupus disorders. Total IgE levels were tested in 117 SLE patients and 61 controls. Eighty-three of the 132 SLE patients (63%) had a history of at least one type of allergic disorder. This prevalence was significantly higher (P < 0.0001) than that of the control group (20 of 66 controls). The prevalence of drug allergy (38% vs. 17%; P < 0.005), skin allergy (36% vs. 17%; P < 0.01) and insect allergy (14% vs. 2%; P < 0.02) were significantly higher in SLE patients when compared with controls. Family members of SLE patients had an increased prevalence of at least one type of allergy (55% vs. 24%; P < 0.0001), allergic rhinitis (30% vs. 14%; P < 0.02), asthma (25% vs. 9% P < 0.02), and both rhinitis or asthma (44% vs. 20%; P < or = 0.002). The presence of allergy both in the patient and in the family was more frequent in SLE patients than controls (42% vs. 15%; P < 0.001). We found no differences in total IgE levels between the two groups. Drug, skin and insect allergies were particularly frequent in SLE patients. We also found a high prevalence of rhinitis and asthma in their families.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369810     DOI: 10.1177/096120339300200311

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF(1) mice.

Authors:  Toshiharu Hayashi; Ayumi Murase
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

2.  The relationship between autoimmunity and specific immunotherapy for allergic diseases.

Authors:  Andrzej Bozek; Krzysztof Kołodziejczyk; Piotr Bednarski
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus.

Authors:  Nicolas Charles; Juan Rivera
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 4.  Genetics of allergic diseases.

Authors:  Romina A Ortiz; Kathleen C Barnes
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

5.  IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus.

Authors:  S Morton; B Palmer; K Muir; R J Powell
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

6.  Atopic diseases and systemic lupus erythematosus: an epidemiological study of the risks and correlations.

Authors:  Yu-Ping Hsiao; Jeng-Dau Tsai; Chih-Hsin Muo; Chung-Hung Tsai; Fung-Chang Sung; Ya-Tang Liao; Yen-Jung Chang; Jen-Hung Yang
Journal:  Int J Environ Res Public Health       Date:  2014-08-08       Impact factor: 3.390

7.  Prevalence and Impact of Reported Drug Allergies among Rheumatology Patients.

Authors:  Shirley Chiu Wai Chan; Winnie Wan Yin Yeung; Jane Chi Yan Wong; Ernest Sing Hong Chui; Matthew Shing Him Lee; Ho Yin Chung; Tommy Tsang Cheung; Chak Sing Lau; Philip Hei Li
Journal:  Diagnostics (Basel)       Date:  2020-11-09

Review 8.  IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target.

Authors:  Yasmine Lamri; Nicolas Charles
Journal:  Antibodies (Basel)       Date:  2020-12-08

9.  Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Adriana A Jesus; Clovis A Silva; Antonio Coutinho; Magda Carneiro-Sampaio
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

10.  Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients.

Authors:  Anna Wozniacka; Anna Sysa-Jedrzejowska; Ewa Robak; Zbigniew Samochocki; Malgorzata Zak-Prelich
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.